# Treatment of Topical Ketorolac Gel in Acute Gouty Flare

> **NCT06273813** · PHASE1 · UNKNOWN · sponsor: **Novilla Pharmaceuticals** · enrollment: 30 (estimated)

## Conditions studied

- Acute Gouty Arthritis
- Acute Pain
- Gout Flare

## Interventions

- **DRUG:** Ketorolac Tromethamine 15 MG/ML
- **DRUG:** Ketorolac Tromethamine

## Key facts

- **NCT ID:** NCT06273813
- **Lead sponsor:** Novilla Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06273813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06273813, "Treatment of Topical Ketorolac Gel in Acute Gouty Flare". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06273813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*